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Hallucinogens, including mescaline, psilocybin,
and lysergic acid diethylamide (LSD), profoundly
affect perception, cognition, and mood. All
known drugs of this class are 5-HT2A receptor
(2AR) agonists, yet closely related 2AR agonists
such as lisuride lack comparable psychoactive
properties. Why only certain 2AR agonists are
hallucinogens and which neural circuits mediate
their effects are poorly understood. By geneti-
cally expressing 2AR only in cortex, we show
that 2AR-regulated pathways on cortical neu-
rons are sufficient to mediate the signaling pat-
tern and behavioral response to hallucinogens.
Hallucinogenic and nonhallucinogenic 2AR
agonists both regulate signaling in the same
2AR-expressing cortical neurons. However,
the signaling and behavioral responses to the
hallucinogens are distinct. While lisuride and
LSD both act at 2AR expressed by cortex
neurons to regulate phospholipase C, LSD re-
sponses also involve pertussis toxin-sensitive
heterotrimeric Gi/o proteins and Src. These
studies identify the long-elusive neural and sig-
naling mechanisms responsible for the unique
effects of hallucinogens.
INTRODUCTION
Throughout history, naturally occurring hallucinogenic
substances such as psilocybin and mescaline have been
recognized for their capacity to alter perception, emotion,
and cognition (Nichols, 2004). All such hallucinogenic
compounds (HCs) exhibit high affinity for 5-HT2A recep-Ntors (2AR) (Gonzalez-Maeso and Sealfon, 2006; Roth
et al., 1998). Genetic or pharmacological inactivation of
2AR signaling blocks the behavioral effects of HCs in
a variety of species, including mice, rats, and humans
(Fiorella et al., 1995; Gonzalez-Maeso et al., 2003; Vollen-
weider et al., 1998). Taken together, these findings indi-
cate that 2AR activation is necessary for the psychoactive
effects of HCs.
The demonstration that HCs elicit their psychoactive
effects via 2AR activation has not resolved the fundamen-
tal paradox that 2AR activation is a universally shared
property of HCs and that 2AR activation is required for
HC effects, but yet not all 2AR agonists exhibit hallucino-
genic activity. Indeed, nonhallucinogenic compounds
(NHCs) such as lisuride and ergotamine share significant
structural similarities and comparable agonist activities
at 2AR (Egan et al., 1998), but lack psychoactive proper-
ties (Pieri et al., 1978).
2AR is expressed widely in the central nervous system
(CNS) and is expressed in structures involved in psycho-
sis—the ventral striatum and ventral tegmental area (Li
et al., 2004; Lopez-Gimenez et al., 1997, 2001; Nocjar
et al., 2002; Pazos et al., 1985). Several of these structures
have also been implicated in HC effects (Nielsen and
Scheel-Kruger, 1986; Vetulani et al., 1979; Willins and
Meltzer, 1997). However, the neuronal substrates that
mediate hallucinogen effects remain obscure.
Our previous study of two HCs, lysergic acid di-
ethylamide (LSD) and 1-(2,5-dimethoxy-4-iodophenyl)-2-
aminopropane (DOI), suggests the hypothesis that HCs
induce a characteristic, 2AR-dependent regulation of gene
expression in mouse somatosensory cortex (SSC) (Gon-
zalez-Maeso et al., 2003). By extending our previous
biochemical studies to a large group of diverse chemicals,
we provide a basis for predicting hallucinogenic potential
from effects in mouse. We find that HC and NHC 2AR
agonists differ in their regulation of signaling and physiol-
ogy in the same neurons in vivo and in vitro. By usingeuron 53, 439–452, February 1, 2007 ª2007 Elsevier Inc. 439
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capacity to cortical neurons in htr2A/ mice, we show
that the unique signaling and neurobehavioral effects of
HCs do not result from their previously proposed regula-
tion of subcortical-cortical circuits, but are intrinsic to
2AR-expressing cortical pyramidal neurons. We formulate
a new model for the mechanism of action of HCs.
RESULTS
HCs Are 2AR Ligands in the Mouse
The responses to HC and NHC 2AR agonists have pre-
dominantly been studied in rats, primates, and humans.
The effects of these drugs in mice have been less well
studied. Because hallucinogens require 2AR activation,
we sought to verify that HCs and NHCs exhibit affinities
to mouse 2AR that are comparable with those seen in
other experimental models. When assayed by displace-
ment of [3H]ketanserin from membranes prepared from
mouse cortex (see Figure S1 in the Supplemental Data),
all agonists displayed affinities that were consistent with
rat and human values (Hoyer et al., 1994). Thus, the 2AR
signaling system in mice presents a tractable model
system to study the effects of HCs.
Acute Behavioral Responses Induced by HCs
Behavioral animal models cannot capture the perturba-
tions of perception, cognition, and mood produced by
HCs in humans. However, rodents might exhibit behav-
ioral proxies of human hallucinogenic effects. Systemic
administration of HCs in rats and nonhuman primates
elicits several unconditioned effects: changes in explor-
atory behavior (Adams and Geyer, 1985a), grooming
(Trulson and Howell, 1984), interruption of operant re-
sponding (Mokler and Rech, 1984), head twitch response
(HTR), ear scratch response (ESR), and hyperthermia
(Corne and Pickering, 1967; Darmani et al., 1990; Maj
et al., 1977; Silva and Calil, 1975).
To identify a mouse model of acute hallucinogenic po-
tential, we examined a variety of responses produced by
several HCs and NHCs (Figure S2). Among the behavioral
measures assayed, only two were elicited by HCs and
notNHCs: theESRandHTR.Othermeasuressuchas loco-
motion, rearing, grooming, and basal body temperature
changes were inconsistently affected by HCs and NHCs
(FigureS2andTablesS1andS2 in theSupplementalData).
The HTR and ESR were both dependent upon the pres-
ence of 2AR signaling capacity, even at a high dose of DOI
(Figure S2). However, the ESR was not elicited by every
HC and was not normally distributed among individual
mice—proving to be an ‘‘all or nothing’’ response. In con-
trast, HTR was reliably and robustly elicited by all HCs
tested. Furthermore, HTR was not produced by NHCs,
and was absent in htr2A/ mice.
All 2AR agonists studied [DOI, 1-(2,5-dimethoxy-
4-methylphenyl)-2-aminopropane (DOM),1-(2,5-dimethoxy-
4-bromophenyl)-2-aminopropane DOB (DOB), psilocin,
mescaline, LSD, ergotamine, R-lisuride, and S-lisuride]440 Neuron 53, 439–452, February 1, 2007 ª2007 Elsevier Incpenetrate the CNS after systemic administration. How-
ever, only the drugs with hallucinogenic potential in
humans (Nichols, 2004) activated a significant HTR in
htr2A+/+ mice, but not in htr2A/ mice (Figure 1A). The
NHC 2AR agonists (ergotamine, R-lisuride, and S-lisuride)
were inactive in both genotypes (Figure 1A). Thus, the
HTR was used as a mouse behavioral proxy of human
hallucinogenic potential in subsequent studies.
HCs Elicit a 2AR Signaling Response Distinct
from NHCs
Consistent with psychoactive effects of certain 2AR
agonists in humans, the HTR was produced only by the
HCs, a subset of drugs with 2AR agonist properties. To
explain this finding, we reasoned that HCs might interact
with 2AR to recruit specific signaling pathways not
activated by NHCs.
To test this hypothesis, we compared HC- and NHC-
activation of multiple signal transduction pathways. Be-
cause signal transduction cascades ultimately regulate
gene transcription (Ruf and Sealfon, 2004), we assessed
HC and NHC signaling by measuring the ‘‘downstream’’
transcriptome responses elicited by HCs and NHCs in
mouse SSC, a responsive and reliable tissue for assessing
the cellular responses of HCs (Gonzalez-Maeso et al.,
2003; Scruggs et al., 2000). We quantified the in vivo in-
duction of 19 transcripts regulated by HCs and NHCs in
htr2A+/+ and htr2A/mice (Tables S3 and S4). Each ago-
nist elicited a differential and reproducible response. To
assess the predictive value of these gene induction re-
sponses on behavior, we used principal components anal-
ysis (PCA) to reduce a 19-dimensional signaling space
(reflected by gene transcripts) to two axes (Figure 1B).
Plotted in this way, the transcriptome responses of HCs
and NHCs predicted their behavioral effects in htr2A+/+
and htr2A/ mice and their hallucinogenic potential in
human (Figure 1B). We selected the most informative
signaling response markers for distinguishing 2AR activa-
tion, as well as HC from NHC by statistical significance
(Tables S5 and S6). Regulation of c-fos tracked with ago-
nist activity at 2AR, and induction of egr-2 and egr-1
most robustly predicted behavioral activity of HCs in
mouse (Figure 1C and Tables S7 and S8).
Activation of Transcriptome Response in Neurons
that Express 2AR
The effects of HCs and NHCs on transcriptome activation
indicated that these compounds interact with 2AR to
activate distinct signaling pathways. This interpretation
implies that the genes induced by HCs and NHCs should
be regulated in neurons expressing 2AR. To test this idea,
we prepared primary cultures of cortical neurons from
htr2A+/+ and htr2A/ mouse embryos. Using fluorescent
in situ hybridization (FISH), we found that both LSD and
R-lisuride induced c-fos expression in neurons expressing
2AR mRNA, while only LSD (but not R-lisuride) induced
egr-2 expression in 2AR-expressing neurons (Figures 2A
and 2B). FISH studies of primary cultures derived from.
Neuron
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nogenic Drugs
(A) Behavioral response to HCs and NHCs.
htr2A+/+ (+/+) and htr2A/ (/) littermates
were injected (i.p.) with the tested compound,
and HTR was scored (n = 6 per treatment
group). Data are means ± SEM. *p < 0.05,
**p < 0.01, ***p < 0.001; Bonferroni’s post hoc
test of two-factor ANOVA. MSC, mescaline;
PSI, psilocin; EGT, ergotamine; R-Ls, R-lisur-
ide; S-Ls, S-lisuride.
(B) PCA in the quantified signaling reporters.
The responses of the first two PCA axes differ-
entiated the cellular effects inducedbyHCsand
NHCs in htr2A+/+ (n = 6–19 mice per group; see
Table S3) and htr2A/ (n = 5–10 mice per
group; see Table S4) determined by qRT-PCR
assays. Only the legends for LSD andR-lisuride
are shown in htr2A/ mice (thicker ellipses).
The ellipse’s center is the mean of the samples
for a particular chemical, and the shape of the
ellipse describes two-dimensional sample vari-
ance of the sample mean, which is the same as
SEM for one-dimensional data.
(C) Comparison of the changes of expression
(log2) in the two most informative reporters,
c-fos and egr-2, for HCs and NHCs in htr2A+/+
and htr2A/ mice. Only the legends for LSD
andR-lisurideareshown inhtr2A/mice (thicker
ellipses). The ellipse’s center is the mean of the
samples, and the shape of the ellipse describes
variance of the mean along each axis.htr2A/ mice showed no induction of these transcripts
by LSD or R-lisuride.
We also studied the role of neuronal action potentials in
HC signaling by determining transcriptome responses in
the presence of tetrodotoxin (TTX). The suppression of
cell firing by TTX did not affect the activation of gene
transcripts in cortical primary culture, thus indicating
that neuronal circuitry could not be involved in the induc-
tion of egr-1 and egr-2 mRNAs. This result indicates that
LSD activation of egr-1 and egr-2 is intrinsic to neurons
with 2AR signaling capacity (Figure S3).
We next used FISH to study whether the different HC
and NHC 2AR-mediated responses also occurred in the
same neurons in vivo. Consistent with other studies
(Lopez-Gimenez et al., 2001), 2AR expression was most
intense in layer V (Figures 2C and 2D), and was also ob-
served in layers II/III (Figures S4 and S5). The 2AR agonist
marker c-foswas induced in layers II/III and V by both LSD
and R-lisuride. Nearly all c-fos-positive cells expressed
2AR mRNA (Figure 2C and Figure S5). LSD induced the
HC-specific marker egr-2 in layer V 2AR-positive neurons
(Figure 2D), but not in layers II/III (data not shown). R-lisur-
ide did not induce egr-2 in SSC. No induction of c-fos or
egr-2 was observed in htr2A/ mice injected with either
LSD or R-lisuride (Figure S6).
Effect of Drug Dose on Transcriptome Response
To establish that the different response patterns obtained
with HCs and NHCs could not be explained by differencesin drug efficacy, we examined the induction of several
transcripts in vitro and in vivo in response to a range of
LSD and R-lisuride doses. As seen in Figure 3, R-lisuride
induced c-fos at doses ranging from 1 to 10 mM in vitro
and 0.4 to 0.8 mg/kg in vivo. R-lisuride did not induce
egr-1 or egr-2 at any dose tested. In contrast, LSD
induced c-fos, egr-1, and egr-2 at doses ranging from 1
to 10 mM in vitro and from 0.24 to 0.96 mg/kg in vivo.
These data show that R-lisuride cannot induce egr-1 or
egr-2 at drug doses up to 10-fold greater than those suffi-
cient to induce c-fos. Transcriptome regulation was
absent at all doses tested in htr2A/ mice and primary
cortical cultures from htr2A/ mice.
Electrophysiological Response to HCs and NHCs
To determine whether the HC-signaling signature reflects
distinct changes in neuronal physiology, we examined the
HC and NHC effects on voltage-gated currents in SSC
slices prepared from htr2A+/+ and htr2A/ mice. We
used standard whole-cell patch-clamp recordings on indi-
vidual layer V pyramidal neurons to study the voltage-
gated currents in the pyramidal neurons in the presence
of TTX. A voltage ramp from110mV to30mV activated
a wide range of ionic currents in these cells that was
altered by the application of HCs in most of the cells
from htr2A+/+ and htr2A/ mice. Since the changes in
current were heterogeneous, we subtracted the HC re-
sponses from baseline responses in the same neuron
(Figure 4B and Figure S7). The resulting HC-inducedNeuron 53, 439–452, February 1, 2007 ª2007 Elsevier Inc. 441
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Hallucinogen Signalling in Cortical NeuronsFigure 2. Colocalization of 2AR and the Genomic Markers c-fos and egr-2 in Mouse SSC and Cortical Primary Cultures
(A and B) Double-label FISH in cortical primary cultures treated for 45 min with vehicle, LSD (10 mM), or R-lisuride (10 mM). (Insets) htr2A/ mice
cortical primary cultures. Red, green, and blue colors indicate 2AR, c-fos (A) or egr-2 (B), and nucleus (DAPI), respectively. (C and B) Double-label
FISH was performed in SSC cortex in mice treated (i.p.) with vehicle, LSD, or R-lisuride. Red, green, and blue colors indicate 2AR, c-fos (C) or
egr-2 (D), and nucleus (DAPI), respectively. (C) shows layers 5 and 6; (D), layer 5. Scale bars: (A, B, and D), 40 mm; (C), 60 mm.responses were divided into three groups based on their
magnitude: small (including no change), medium, and
large (see Table S9). Small and medium currents were
observed in cells fromboth htr2A+/+ and htr2A/mice, in-
dicating that they were 2AR-independent. However, large
currents were only observed in cells from htr2A+/+ mice
treated with LSD (Figures 4B and 4D and Table S9). These
LSD-induced large currents were seen in approximately
25% of the cells tested, and exhibited an average charge
of 334 ± 97 C and a reversal potential of 67.5 ± 2.4 mV,
suggesting that they represented the sum of several
different currents. This large current was never observed
with R-lisuride (Figures 4C and 4D).
Lisuride and LSD Compete for the Same Receptor
Target
Our findings demonstrate that both LSD and R-lisuride
require a functional 2AR to generate their signaling
profiles. R-lisuride displaces [125I]LSD with high affinity442 Neuron 53, 439–452, February 1, 2007 ª2007 Elsevier Inc.from 2AR-expressingmembrane preparations (Figure 4A),
suggesting that they compete for the same binding site.
However, we reasoned that it is possible that LSD and
R-lisuride might interact with receptor targets other than
2AR, which would explain their distinct effects on signal-
ing and behavior. To test this possibility, we first studied
whether R-lisuride demonstrated competitive and/or ad-
ditive effects with LSD in different measures. We found
that R-lisuride blocked the LSD-induced large currents
in SSC neurons (Figures 4C and 4D). Furthermore, we
observed that pretreatment of mice with R-lisuride pre-
vented LSD-mediated induction of egr-1 and egr-2 in vivo,
whereas the induction of c-foswas unaffected (Figure 4E).
The combined effects of LSD and R-lisuride adminis-
tration on c-fos induction were not additive, a result
incompatible with a model where each drug stimulates
c-fos through different receptors. Furthermore, LSD-
induced HTR (Figure 4F) was prevented when the
animals were first pretreated with R-lisuride. These
Neuron
Hallucinogen Signalling in Cortical NeuronsFigure 3. Comparable 2AR-Dependent Signaling Responses In Vivo and in Cortical Primary Cultures
(A) Concentration-response curves of LSD- or R-lisuride-induced cellular response in cortical primary culture assayed by qRT-PCR. htr2A+/+ (+/+) or
htr2A/ (/) mouse cortical primary cultures were treated for 45 min with the indicated concentration (n = 4–12 per group).
(B) Dose-response curves of LSD- or R-lisuride-induced cellular response inmouse SSC cortex assayed by qRT-PCR. htr2A+/+ (+/+) or htr2A/ (/)
mice were injected (i.p.) with the doses indicated (n = 4–8 mice per group). Drug-induced changes in expression levels are reported as fold change
over vehicle. Data are means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001; Bonferroni’s post hoc test of two-factor ANOVA.pharmacological data suggest that R-lisuride and LSD
target the same population of 2AR to induce distinct
effects on electrophysiology, intracellular signaling, and
behavior.
Lisuride is not simply a 2AR agonist, but also interacts
with a variety of central monoamine receptors, including
dopamine and 5-HT1A receptors. These other receptors
have been proposed as candidates targeted by lisuride
that may integrate with 2AR signaling to prevent the in-
duction of hallucinogenic response (Callahan and Appel,
1990; Marona-Lewicka et al., 2002).
In order to evaluate the potential role of dopaminergic
receptors in the modulation of the responses to LSD
elicited by R-lisuride, we tested the cellular response in
SSC in vivo and the behavioral response induced by
LSD after preinjection with SKF82958 or quinpirole, D1-
like and D2-like receptor agonists, respectively. Neither
of the dopaminergic agonists alone induced egr-1 or
egr-2 in mouse cortex (Figure 5A), nor did they affect
HTR (Figure 5B). The expression of c-fos was unaffected
by quinpirole, whereas c-fos was induced by SKF82958
(Figure 5A). The combined effects of SKF82958 and LSD
administration on c-fos induction were additive, which
was opposite to the effects of coadministration of R-lisur-
ide and LSD (see above). When combined with LSD, nei-
ther SKF82958 nor quinpirole affected the induction of
the HC-specific egr-1 or egr-2 genes (Figure 5A). Further-
more, the LSD-induced HTR was not affected by eitherSKF82958 or quinpirole (Figure 5B). These results suggest
that the effects of LSD and lisuride arise from interaction
with the same 2AR target, and that their effects do not
result from activity at dopamine receptors.
Lisuride is a full agonist in modulation of [35S]GTPgS
binding in membranes of CHO cells expressing 5-HT1A
receptors (McLoughlin and Strange, 2000). Several be-
havioral assays have also confirmed the high efficacy of
lisuride at 5-HT1A receptors (Millan et al., 1991; Rex
et al., 1998). It has been suggested that coactivation of
5-HT1A receptors (htr1A) and 2AR by lisuride could explain
why lisuride acts as a 2AR agonist, yet lacks hallucino-
genic properties (Marona-Lewicka et al., 2002). We tested
this hypothesis by examining the behavioral effects of LSD
and R-lisuride in htr1A+/+ and htr1A/ mice. Because
both of these compounds are 2AR agonists, coactivation
of 5-HT1A receptors by LSD or R-lisuride should attenuate
their hallucinogenic properties. Thus, the behavioral
responses to each compound should be augmented in
the htr1A/ mice. As shown in Figure 5C, this was not
the case. There was no significant effect of genotype
on the behavioral response to either R-lisuride or LSD.
Taken together, our results suggest that neither dopamine
nor 5-HT1A receptor activation functionally antagonize
2AR-dependent effects mediated by R-lisuride, and indi-
cate that R-lisuride and LSD interact with the samemolec-
ular target to induce distinct effects on electrophysiology,
intracellular signaling, and behavior.Neuron 53, 439–452, February 1, 2007 ª2007 Elsevier Inc. 443
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Same Population of 2AR
(A) [125I]LSD competition curve by R-lisuride.
R-lisuride displaced [125I]LSD in membrane
preparations from HEK293 cells stably ex-
pressing human 2AR.
(B) Effect of LSD on voltage ramp-activated
ionic currents. Residual LSD-evoked currents
were observed in single neurons in htr2A+/+
and htr2A/ mice, after subtraction of current
prior to LSD (1 mM) application (holding poten-
tial [Vh] = 70 mV, ramp from 110 to 30 mV
in 3.5 s).
(C) R-lisuride (5 mM) blocked the effect of LSD
on currents elicited by voltage ramp. Applica-
tion of R-lisuride did not alter the baseline
responses in neurons from htr2A+/+ mice, but
abolished the effect of LSD. Scale bars, 100
pA, 500 ms.
(D) Summary of currents elicited by voltage
ramp in box plots (n = 11–19). Responses
with large amplitude seen in neurons from
htr2A+/+ mice were absent in neurons after
preincubation with R-lisuride (p < 0.05), or in
neurons from htr2A/ mice (p < 0.05).
(E) Cellular response was determined in SSC in
mice injected with LSD 15 min after being
preinjected with a high dose of R-lisuride (0.8
mg/kg; n = 5–8 per group). Data are means ±
SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
(F) HTR was determined in mice injected with
LSD 15 min after being preinjected with a high
dose of R-lisuride (0.8 mg/kg; n = 3–6 per
group). R-lisuride blocks the LSD-inducted
behavioral response. Data are means ± SEM.
*p < 0.05, **p < 0.01, ***p < 0.001; ANOVA
with Bonferroni’s post hoc test.Receptor Signaling Response to HCs and NHCs
HCs and NHCs induce different transcriptome responses
in cortical neurons that express 2AR. We next investi-
gated the signaling cascade responsible for the unique
transcriptional responses elicited by HCs. 2AR activates
phospholipase C-b (PLC-b) via heterotrimeric Gq/11 pro-
teins, leading to increased accumulation of inositol
phosphates and intracellular calciummobilization (Barnes
and Sharp, 1999). We first examined the role of this path-
way in the HC-specific responses in primary cortical
cultures by studying the gene responses after pretreat-
ment with the PLC-b inhibitor U73122. Inhibition of
PLC-b eliminated the gene response obtained by either
LSD or R-lisuride (Figure 6A). These results suggest that
the classical Gq/11-PLC-b 2AR signaling pathway is
required for the response to HCs, but is not unique and
specific to HCs.
We previously discovered that the neuroprotective
effects of some agonists acting at the dopamine D2 recep-
tor result from the capacity of these agonists to regulate
a signaling pathway in addition to the classical Gi/o protein
pathway that is known to couple with that receptor (Nair444 Neuron 53, 439–452, February 1, 2007 ª2007 Elsevier Inc.and Sealfon, 2003). The classical PLC-b response is reg-
ulated by both HCs and NHCs acting at 2ARs. HCs elicit
unique 2AR-dependent gene, signaling pattern, and be-
havioral responses (see above). We speculated that the
HC 2AR complexes might cause regulation of an addi-
tional signaling pathway that is not affected by NHC 2AR
complexes. Some reports have implicated pertussis toxin-
(PTX-) sensitive Gi/o proteins in the cellular responses
mediated by 2AR (Kurrasch-Orbaugh et al., 2003; Ray-
mond et al., 2001). To explore the consequences of Gi/o
protein inhibition on the 2AR-induced transcriptome
changes, the cortical primary cultures were pretreated
with PTX. While PTX did not affect the gene responses to
R-lisuride, it greatly attenuated the responses elicited by
LSD (Figure 6B). These results suggest that the gene re-
sponse elicited by LSD requires a coactivation of Gi/o and
Gq/11 proteins that is unique to HCs.
In several cell types, Gi/o protein-regulated phosphory-
lation networks involve Gbg subunit-mediated activation
of Src (Banes et al., 1999; Crespo et al., 1994; Gutkind,
2000; Quinn et al., 2002). Therefore, we tested the effects
of Src inhibition on the 2AR-mediated gene responses
Neuron
Hallucinogen Signalling in Cortical NeuronsFigure 5. Effect of D1-Like, D2-Like, and
5-HT1A Receptor Signaling on the
Responses to LSD
(A) Cellular response was determined in SSC in
mice injected with vehicle or LSD 15 min after
being preinjected with vehicle, SKF82958
(1 mg/kg), or quinpirole (1 mg/kg). Data are
means ± SEM (n = 6–8 per group). *p < 0.05,
**p < 0.01, ***p < 0.001; ANOVA with Bonferro-
ni’s post hoc test.
(B) HTR was determined in mice injected with
vehicle or LSD 15 min after being preinjected
with vehicle, SKF82958 (1 mg/kg), or quinpirole
(1 mg/kg). Data are means ± SEM (n = 7–11 per
group). *p < 0.05, **p < 0.01, ***p < 0.001;
ANOVA with Bonferroni’s post hoc test.
(C) Behavioral response (HTR) of htr1A+/+ and
htr1A/mice to LSD (0.24 mg/kg) and R-lisur-
ide (0.4 mg/kg). Data are means ± SEM. n = 4
to 7 per genotype. ***p < 0.001 for drug versus
vehicle; not significant for genotype effects.induced by LSD and lisuride. The gene response pattern
to R-lisuride was unaffected by inhibition of Src. However,
the response to LSD in the presence of Src inhibitor was
dramatically affected so as to be indistinguishable fromthe response to R-lisuride (Figure 6B). G protein-coupled
receptors (GPCRs) may also activate phosphatidylinosi-
tol-3 kinases (PI-3-K) via Gbg subunits (Gutkind, 2000).
Pretreatment with the PI-3-K inhibitor LY294002 had noFigure 6. LSD-Specific Signaling in Pri-
mary Cortical Neurons
(A) Gene regulation by both LSD and R-lisuride
is eliminated by inhibition of PLC-b with
U73122 (10 mM; 30min). (B) The gene induction
pattern induced by LSD is specifically attenu-
ated by inhibition of Gi/o protein with PTX (100
ng/ml, overnight), and by inhibition of Src with
PP2 (10 mM; 30 min). The responses to both
drugs are not affected by inhibition of PI-3-K
with LY294002 (10 mM; 30 min). Note that the
responses to R-lisuride are unaffected by Src
inhibition, and that the responses to LSD and
R-lisuride are identical in the absence of
Src activity. Data are means ± SEM. *p <
0.05, **p < 0.01, ***p < 0.001; ANOVAwith Bon-
ferroni’s post hoc test (n = 6–12 per group).Neuron 53, 439–452, February 1, 2007 ª2007 Elsevier Inc. 445
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Hallucinogen Signalling in Cortical NeuronsFigure 7. Restoration of Cortical Expression of 2AR Recreates Wild-Type Expression Pattern and Binding Capabilities
(A) Brain mapping of the genomic markers induced by LSD and R-lisuride. OB, olfactory bulb; PFC, prefrontal cortex; Cg, cingulate cortex; SSC,
somatosensory cortex; PiC, piriform cortex; HC, hippocampus; Thal, thalamus; CB, cerebellum (n = 6 per group; see Tables S10 and S11).
(B) [125I]DOI autoradiography in htr2A+/+, htr2A/, and htr2A/:Emx1-Cre+/ mice.
(C) [3H]Ketanserin saturation curves in htr2A+/+, htr2A+/, htr2A/, and htr2A/:Emx1-Cre+/ mice SSC membranes.effect on either the LSD- or R-lisuride-mediated transcrip-
tome response. These results indicate that 2AR activation
by LSD causes a specific regulation of Gi/o protein and Src
that is responsible for the unique HC pattern of gene
induction.
Neuronal Specificity of HC-Specific Signaling
Pathways
Although we used SSC as our experimental model of HC-
induced signaling and electrophysiology, it remained un-
clear whether the HC signaling response could be pro-
duced by 2AR expressed on other neuronal populations
in the CNS. To address this question, we examined
egr-1, egr-2, and c-fos induction by LSD and R-lisuride
in several 2AR-expressing brain regions (Figure 7A, Tables
S10 and S11). With the exception of the hippocampus,
LSD and R-lisuride activated c-fos in all brain regions ex-
amined. LSD induction of egr-1 and egr-2was observed in
cortical structures and the olfactory bulb (Figure 7A, Ta-
bles S10 and S11), but not in structures such as the thal-
amus or cerebellum. In contrast, R-lisuride failed to induce
egr-1 or egr-2 in any brain region examined. This finding
indicates that certain populations of neurons may be
unique in their capacity to generate 2AR-mediatedHC sig-
naling. Moreover, these findings implicate cortical 2AR
signaling as a likely mediator of HC effects on behavior.446 Neuron 53, 439–452, February 1, 2007 ª2007 Elsevier InGenetic Restoration of 2AR Expression to the Cortex
of htr2A/ Mice Rescues HC-Induced Signaling
and Behavior
To test the hypothesis that cortical 2AR signaling is inte-
gral to the effects of HCs, we used a genetic strategy to
selectively restore 2AR expression to the cortex of
htr2A/ mice. The htr2A/ mice used in this study con-
tain a transcriptional/translational termination sequence
inserted between the promoter and the first coding exon
(Figure S8). This so-called ‘‘stop’’ cassette was flanked
by lox-P sequences, allowing it to be excised by the bac-
teriophage P1 recombinase, Cre. To restore 2AR expres-
sion to the cortex of htr2A/mice, we crossed them with
a second line of mice expressing Cre recombinase under
the control of the Emx1 promoter. The homeobox gene
Emx1 is expressed in the forebrain during early brain mat-
uration (Boncinelli et al., 1993), and has been used previ-
ously to control forebrain gene expression (Iwasato
et al., 2000).
Because the htr2A coding region remains under the
control of its endogenous promoter, rescue of 2AR ex-
pression was expected to occur only in tissues where
the expression patterns of the htr2A and Emx1 promoters
overlap. Emx1 is expressed in glutamatergic neurons of
the forebrain (Gorski et al., 2002); thus, we predicted
that Emx1-Cre should restore 2AR expression only to cor-
tical glutamatergic neurons (one of the only structuresc.
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Hallucinogen Signalling in Cortical NeuronsFigure 8. Cortical 2AR Function Mediates Cellular and Behavioral Responses Induced by Hallucinogens
(A) htr2A+/+, htr2A/, and htr2A/:Emx1-Cre+/micewere injectedwith vehicle, LSD, or R-lisuride, and the cellular responsewas determined in SSC
by qRT-PCR (n = 4–8 per group). Data are mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
(B) Effect of LSD on voltage ramp-activated ionic currents in htr2A/ and htr2A/:Emx1-Cre+/ mice. Scale bars, 100 pA, 500 ms (n = 16).
(C) htr2+/, htr2A/, and htr2A/:Emx1-Cre+/ mice were injected with vehicle, LSD, or R-lisuride, and the head twitch behavioral response was
scored (n = 4–6 per group). Data are mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001; Bonferroni’s post hoc test of two-factor ANOVA.where 2AR and Emx1 are coexpressed). We confirmed
the predicted cortical pattern of 2AR expression in the res-
cue line using [125I]DOI autoradiography and radioligand
binding assays (Figure 7). Using FISH, we also determined
that expression of 2AR was localized primarily to pyrami-
dal cortical neurons (data not shown). In contrast, 2AR
expression was absent in striatum, thalamus, and amyg-
dala—tissues expressing 2AR, but not Emx1 (Figures 7B
and 7C).
Because of the breeding strategy required to generate
htr2A/:Emx1-Cre+/ mice (see Experimental Proce-
dures), they are heterozygous for 2AR expression in cor-
tex. We found that the level of 2AR expression in the cor-
tex of htr2A/:Emx1-Cre+/mice was comparable to that
in htr2A+/ mice, indicating a high efficiency of Cre-medi-
ated recombination (Figure 7C). We have previously found
that loss of a single allele in htr2A+/ mice does not inter-
fere with their behavioral response to HCs (data not
shown). Therefore, htr2A+/ littermates were deemed ap-
propriate controls for testing htr2A/:Emx1-Cre+/mice.
Restorationof2AR in thecortexofhtr2A/:Emx1-Cre+/
mice was sufficient to rescue signaling and behavioral
responses to LSD (Figure 8). Specifically, LSD activated
HTR behavior, electrophysiological response, and the
HC-specific markers egr-1 and egr-2 in htr2A/:Emx1-
Cre+/mice to levels seen in htr2A+/mice. The specificity
of the hallucinogen properties wasmaintained in htr2A/:
Emx1-Cre+/mice, as R-lisuride activated neither HTR noregr-1/egr-2 expression in cortical rescue or htr2A+/
control mice.
DISCUSSION
Our study addresses the mechanisms by which HCs elicit
their psychoactive effects. We found that while both HCs
and NHCs show agonist activity at cortical 2AR in vivo,
the HCs elicit a characteristic and predictive signaling
response not shared by NHCs. The HC transcriptome
signaling signature was absent in htr2A/ mice, but was
produced both in htr2A+/+ mice and in their cultured corti-
cal neurons. Inhibitor studies in primary neuronal cultures
revealed that the HC-characteristic transcriptome re-
sponse to LSD depends on its specific regulation of Gi/o
proteins and Src. We also demonstrated that genetic res-
toration of 2AR signaling capacity to cortical neurons of
htr2A/ mice was sufficient to rescue the HC-specific
signaling signature and behavioral response.
Implications for Other Hypotheses of HC Effects
In this study, our observations point to a specific HC
interaction with cortical 2AR to explain its unique proper-
ties. However, other hypotheses have been proposed to
account for the different effects of HC and NHC 2AR
agonists on behavior. In the course of this study, we have
tested and eliminated several of these alternative explana-
tions for our results.Neuron 53, 439–452, February 1, 2007 ª2007 Elsevier Inc. 447
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Hallucinogen Signalling in Cortical NeuronsFigure 9. Model of the Mechanism Un-
derlying HC-Specific-Induced Behavioral
Response
This schematic presents a model for the mech-
anism of HCs that is consistent with our exper-
imental results. The two left panels illustrate the
responses in htr2A+/+mice. Both LSD and lisur-
ide act at receptors expressed by cortical pyra-
midal neurons. However, the receptor confor-
mation stabilized by LSD is proposed to be
distinct, leading to the different pattern of cellu-
lar signaling and physiological and neurobeha-
vioral responses observed. The characteristic
cellular signaling responses to LSD and lisuride
were also obtained in cortical primary cultures
(not illustrated). The two right panels show the
interpretation of the results obtained in the ge-
netic models studied. The cellular signaling and
physiological and behavioral responses to HCs
were eliminated in htr2A/ mice, but rescued
by genetic restoration of 2AR to cortical pyramidal neurons (htr2A/:Emx1-Cre+/ mice). As the effects of HCs are restored in the cortical rescue
mouse, the unique effects of HCs cannot involve regulation of subcortical-cortical circuits and must be intrinsic to 2AR-expressing cortical neurons.
Thus, HCs and NHCs act at 2AR on the same cortical pyramidal neurons, but only HCs stabilize a receptor conformation that recruits the signaling
pathways responsible for their neurobehavioral effects.Lisuride is well known to have significant agonist activity
at dopamine receptors (Millan et al., 2002; Newman-
Tancredi et al., 2002). Some researchers have suggested
that the differences between LSD and lisuride result from
the greater dopamine receptor agonism of lisuride (Adams
and Geyer, 1985b; Callahan and Appel, 1990; Horowski
and Wachtel, 1976). However, we find that dopaminergic
receptor activation does not affect the 2AR-dependent
responses selectively induced by LSD (See Figure 5).
The finding that the induction of c-fos was synergistically
induced by LSD and SKF82958, but not by LSD and R-
lisuride, suggests that R-lisuride does not modulate the
induction of c-fos in cortex by targeting D1-like receptors.
It has also been proposed that 5-HT1A receptor stimula-
tion counteracts 2AR effects on HC-specific behaviors
(Marona-Lewicka et al., 2002).We examined this hypothe-
sis by assessing the effect of R-lisuride and LSD in mice
lacking 5-HT1A receptors. We found that R-lisuride did
not significantly induce HTR in htr1A+/+ or htr1A/ mice.
The activating effects of LSD on HTR behavior were com-
parable between htr1A+/+ and htr1A/ mice. These find-
ings indicate that the 5-HT1A receptor signaling properties
of HCs and NHCs do not affect their potential to elicit
a behavioral response in mice. Overall, these results
further support the hypothesis that LSD and R-lisuride tar-
get the same population of 2AR in mouse cortex, yielding
different responses. Notably, some cellular responses
(e.g., IkBa induction in SSC) or behavioral responses
(e.g., grooming) induced by R-lisuride in ht2A/ mice
might result from activity at dopaminergic and/or 5-HT1A
receptors.
Another departure from prior paradigms was our finding
that c-fos was induced primarily in neurons that express
2AR. Earlier reports have suggested that c-fos is induced
by HCs mostly in neurons that do not express 2AR, imply-
ing an indirect mechanism for HC effects (Gresch et al.,448 Neuron 53, 439–452, February 1, 2007 ª2007 Elsevier Inc.2002; Scruggs et al., 2000, 2003). Here we found that
this is not the case. These divergent results may be expli-
cable by our use of FISH, rather than immunohistochem-
istry, as our primary method of assessing 2AR expression.
Neuronal Target of HCs
Our findings also bear on the hypothesized role of thalamic
2AR in the mechanism of action of HCs. Previous studies
have suggested that 2AR expressed on thalamocortical
axon terminals activates glutamate release in the cortex
(Marek et al., 2001; Scruggs et al., 2000, 2003). Our
htr2A/:Emx1-Cre+/ rescue line shows a selective res-
toration of 2AR expression in the cortex. As 2AR expres-
sion is not restored in the thalamus, 2AR should not be
expressed on the cortical terminals of thalamic neurons
in thesemice. The expression of 2AR in the cortex neurons
alone was sufficient to elicit HC-specific behavioral and
signaling effects (Figure 8). In contrast, 2AR restoration
exclusively to the thalamus did not restore HC-induced
behaviors (data not shown). Although previous studies
implied that the effects of HCs require the release of gluta-
mate (see above), our data suggest that the circuit in-
volved in this effect is a cortical-cortical circuit and does
not require activation of a thalamocortical pathway. In
addition, HC-specific signaling patterns could be obtained
in primary cortical cultures in the absence of action poten-
tials and thalamic neurons. The HC-specific gene signa-
ture was observed in neurons that express 2AR mRNA
both in vivo and in primary culture experiments. Thus,
several lines of evidence indicate that cortical pyramidal
neurons expressing 2AR are the cellular targets responsi-
ble for HC effects (Figure 9).
Implications of Distinct HC Signaling at Cortical 2AR
We found that HCs and NHCs activate the expression
of overlapping, but distinct, genes. For example, we
Neuron
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naling common to all 2AR agonists. On the other hand,
egr-1 and egr-2were induced by all HCs used in our study,
but not by any NHC tested. However, the regulation of the
upstream pathways and not the changes in gene expres-
sion are responsible for the physiological and behavioral
response to HCs. This view is consistent with our observa-
tion that HTR was activated within minutes of drug admin-
istration, whereas gene induction often reached maximal
levels at about 1 hr (Gonzalez-Maeso et al., 2003). More-
over, mice deficient in egr-1 exhibit normal behavioral
responses to DOI (data not shown).
We took advantage of the consonant differences in the
gene expression patterns obtained both in vivo and
in vitro by LSD and R-lisuride to identify the pathways
responsible for the unique effects of HCs. Inhibition of
PLC-b fully abolished the responses to both LSD and
R-lisuride. However, PTX only affected the responses to
LSD, without affecting the response to R-lisuride. These
data indicate that 2AR generates different heterotrimeric
G protein-dependent signaling responses when activated
by LSD or R-lisuride.
Additional experiments were conducted to explore the
HC-mediated neuronal signaling pathways. In the pres-
ence of 3-(4-chlorophenyl) 1-(1,1-dimethylethyl)-1H-pyra-
zolo[3,4-d]pyrimidin-4-amine (PP2), which specifically in-
hibits Src, the transcriptome response induced by LSD
in cortical primary culture was indistinguishable from the
one induced by R-lisuride. These data map out a 2AR-
dependent signaling cascade specifically activated by
HCs, linking Gi/o protein and Src. The effects of Src inhibi-
tion on the HC-specific component of the transcriptome
signaling signature are more complete than the effects
of PTX. This observation raises the possibility that the
LSD-induced signaling between 2AR and Src may involve
parallel pathways in addition to Gi/o proteins that are not
yet identified. Nonetheless, as discussed below, these
findings provide strong support for the hypothesis that
the remarkable neuropsychological responses to HCs
result from their stabilization of specific 2AR conforma-
tional states, leading to distinct regulation of intracellular
signaling pathways.
Agonist Trafficking as a Potential Mechanism
of Action of HCs
Our results support the hypothesis that HCs and NHCs,
while acting at the same 2AR expressed by cortical
neurons, elicit different patterns of signaling that are
responsible for their different behavioral activities.
The interpretation that different agonists acting at 2AR
regulate different signaling pathways is consistent with
recentpharmacological theory andexperiments. The stan-
dard pharmacological model of GPCR activation, the
ternary complex model (De Lean et al., 1980), postulates
that the efficacy of ligands depends on their ability to shift
the equilibrium between two conformational states: inac-
tive and active (Kenakin, 2002). However, both theory
and experimental evidence suggest that GPCRs adoptmultiple conformations when activated by different ago-
nists (Berg et al., 1998; Ghanouni et al., 2001; Gonzalez-
Maeso et al., 2003; Nair and Sealfon, 2003; Prioleau
et al., 2002). This expanded version of the ternary complex
model posits that different receptor agonists stabilize dis-
tinct conformations that preferentially recruit and activate
specific signaling pathways (Kenakin, 2003; Urban et al.,
2006). Our observations are consistent with such a model
as it explains how distinct cellular responses could be
produced by HC and NHC interactions with cortical 2AR
(Figure 9). As predicted by this model, the activation of
HC-specific gene activation patterns was found over-
whelmingly in 2AR-expressing neurons, indicating that
these signaling pathways were intrinsic to 2AR activation
and not the result of indirect activation via action poten-
tials or neuronal circuits.
Concluding Remarks
Our data suggest that cortical neurons may be unique in
their capacity to generate the specific signaling pathways
of HCs. 2AR is expressed in subcortical brain regions of
htr2A+/+ mice, yet 2AR expression was not rescued in
these areas of htr2A/:Emx1-Cre+/ mice, indicating
that subcortical populations of 2AR are not required for
HC actions. 2AR is most highly expressed in layer V pyra-
midal neurons (Lopez-Gimenez et al., 2001). Because
layer V functions as the ‘‘output’’ layer of the cortex (Sapi-
enza et al., 1981), it has been hypothesized that layer
V neurons engage in ‘‘gating’’ functions that are of critical
importance to the proper balance between cortical-sub-
cortical communications (Barkai and Hasselmo, 1994). It
is reasonable to suspect that 2AR-mediated HC signaling
may perturb the normal gating functions of layer V cortex,
disrupt cognition and sensory processing, and lead to the
characteristic HC effects on behavior.
The strategy we developed to elucidate HC action
should be applicable to CNS-active compounds, with
therapeutic potential in other disorders. Thus, our findings
may advance the understanding of neuropsychiatric dis-
orders that have specific pharmacological treatments
whose mechanisms of action are not fully understood.
EXPERIMENTAL PROCEDURES
Experimental Animals
Experiments were performed on adult (8–12 weeks old) male 129S6/
SvEv mice. For experiments involving genetically modified mice,
htr2A+/+ or htr2A+/ littermates were used as controls. Animals were
housed in 12 hr light/dark cycle at 23Cwith food and water ad libitum.
The Institutional Animal Use and Care Committee approved all experi-
mental procedures at Columbia University and Mount Sinai School of
Medicine.
Cortical Rescue of 2AR in htr2A/ Mice
Generation of htr2A/mice has been described previously (Gonzalez-
Maeso et al., 2003). To generate htr2A/mice, a transcriptional termi-
nation sequence (NEO-STOP) was placed between the promoter and
the coding sequence. Using Emx-Cre-recombinase, this transcrip-
tional termination sequence (flanked by lox-P sites) is excised fromNeuron 53, 439–452, February 1, 2007 ª2007 Elsevier Inc. 449
Neuron
Hallucinogen Signalling in Cortical Neuronshtr2A/ mice, rescuing receptor expression in brain regions where
their expression pattern overlaps (Figure S8).
Drug Administration
DOI, DOM, DOB, dimethyltryptamine (DMT), andmescaline (Sigma-Al-
drich) were dissolved in saline and injected i.p. LSD, R-lisuride, S-lisur-
ide, and ergotamine (Sigma-Aldrich) were injected i.p. after suspen-
sion in a minimal amount of DMSO and made up to volume with
normal saline. Psilocin (Sigma-Aldrich) was dissolved in distilled water
supplemented with a minimal amount of acetic acid and injected i.p.
The injected doses were DOI, 2 mg/kg; DOM, 4 mg/kg; DOB, 1 mg/
kg; DMT, 15 mg/kg; mescaline, 20 mg/kg; LSD, 0.24 mg/kg; psilocin,
2 mg/kg; ergotamine, 0.5 mg/kg; R-lisuride, 0.4 mg/kg; and S-lisuride,
4 mg/kg, unless otherwise indicated. Quinpirole (1 mg/kg; Tocris
Bioscience) and SKF82958 (1 mg/kg; Sigma-Aldrich) were dissolved
in saline and injected i.p.
Behavioral Studies
Head twitch behavioral response was evaluated as previously
described (Gonzalez-Maeso et al., 2003). The following events were
scored 15 min following injection with drug or vehicle for a period of
20 min. ESR was scored as previously described (Darmani et al.,
1990). Locomotor activity was measured by counting the number of
transitions across 6 equally sized squares on the floor of a 30 cm 3
15 cm arena. Grooming was assessed as event bouts separated by
a minimum of 10 s. Rearing events were scored when a mouse raised
itself into a near vertical position on its two hind legs. Temperature
change was measured using a Vaseline-lubricated 2 cm thermocou-
ple-measuring device inserted into the mouse rectum prior to drug
injection (T0) and at the end of the 20 min test period (T1). Temperature
change was calculated by subtracting T1 from T0.
Mouse Brain Samples
Experiments were performed as previously described, with minor
modifications (Gonzalez-Maeso et al., 2003). Drugs (see above) or
vehicle was injected i.p., and mice were sacrificed by cervical disloca-
tion 60 min after the injection. The brain was dissected, frozen on dry
ice, and stored at 80C for total RNA isolation.
Quantitative Real-Time PCR
Quantitative real-time PCR (qRT-PCR) experiments were performed
as previously reported (Gonzalez-Maeso et al., 2003).
PCA Analysis of qRT-PCR
The fold change ratios for each pair of experimental and control
samples for 19 genes from the qRT-PCR (see above) were transformed
by log2 function. PCA was carried out using the open source software
Language R function ‘‘princomp’’ (Ihaka and Gentleman, 1996). For
each sample, the log2 fold change ratio of the 19 genes can be pro-
jected onto a plane consisting of the first two components (Johnson
and Wichern, 1982). Each sample is then represented by one dot on
a two-dimensional plane.
[125I]DOI Autoradiography Binding Assay
Fresh frozen brains from were cut into 14 mm sagittal sections, then
thaw-mounted to SuperFrost (Fisher Scientific) slides. Sections were
preincubated in assay buffer (4 mM CaCl2, 0.1% ascorbic acid, and
50mMTris-HCl [pH7.4]) for 30min in thepresenceof a 5-HT2C receptor
antagonist (SB242084; 100 nM). Then sections were transferred to as-
say buffer containing 200 pMof [125I]DOI and incubated for 1 hr at room
temperature. Sections were washed with ice-cold assay buffer two
times for 10 min and two times for 5 min, and then rinsed with cold dis-
tilled water for 1min. Air-dried sections were exposed to film overnight.
[3H]Ketanserin and [125I]LSD Binding Assays
Brain cortical membrane preparations were performed as previously
reported, with minor modifications (Gonzalez-Maeso et al., 2002).450 Neuron 53, 439–452, February 1, 2007 ª2007 Elsevier Inc[3H]Ketanserin (DuPont-NEN) was used to label 2AR in saturation
and competition assays as previously reported (Ebersole et al.,
2003). Nonspecific binding was determined in the presence of 10 mM
methysergide (Tocris Cookson Inc.).
HEK293 cell membrane preparations were performed as previously
reported, with minor modifications (Ebersole et al., 2003). [125I]LSD
(PerkinElmer) was used to label 2AR. Binding assays were incubated
for 60 min at 37C in a total volume of 500 ml, 100 pM [125I]LSD in
the absence or presence of R-lisuride as displacer. Nonspecific
binding was determined in the presence of 1 mM ketanserin (Tocris
Cookson Inc.).
Electrophysiology
Coronal sections (400 mm) were obtained from P10–20 mice following
decapitation and brain dissection in chilled artificial cerebrospinal fluid
(ACSF; 125 mMNaCl, 2.5 mMKCl, 1.25 mMNaH2PO4, 1 mMMgCl2, 2
mM CaCl2, 25 mM NaHCO3, and 25 mM glucose), using a Vibratome
1000 (Vibratome, St. Louis). Slices were allowed to recover for 1 hr at
room temperature before use. TTX (Sigma-Aldrich), LSD, and R-lisur-
ide were prepared as stock solutions, and diluted in ACSF to final
concentrations daily before use. All drugs were applied via bath perfu-
sion. Brain slices were placed in a recording chamber on an upright
microscope (Olympus BX51-WI) and continuously perfused with
oxygenated ACSF at 30C. Whole-cell patch-clamp (ruptured) record-
ings were performed using an Axopatch 700B amplifier (Axon Instru-
ments). Data were acquired and analyzed using pClamp9 software
(Axon Instruments, Sunnyvale). Borosilicate glass pipettes (Warner
Instrument Corp, 5–8 MU) were filled with: 130 mM CsCl, 2 mM
CaCl2, 10 mM HEPES, 11 mM EGTA, 3 mM Mg-ATP, 0.4 mM Na-
GTP (pH 7.4; 265275 mOsm/l). Alexa Fluor 594 hydrazide (100 mM;
Invitrogen) was added to the internal solution for visualizing the
morphology of recorded neurons. Pyramidal neurons were identified
based on layer location and morphology. Neurons were voltage-
clamped at 70 mV and voltage ramps (from 110 to 30 mV in 3.5
s) were given every 30 s during baseline and drug application. Drugs
were applied for 8 min only after stable responses were obtained in
five successive trails. Only cells that maintained a stable access resis-
tance throughout the experiment (less than 5% of change) were
included in analysis. At the end of each experiment, morphology of
the recorded neuron was examined to confirm the cell type.
Fluorescent In Situ Hybridization
Synthesis of modified DNA oligonucleotide probes, probe labeling,
and FISH was performed as previously described (Chan et al., 2005).
See Table S12 for oligonucleotide probe sequences.
Cortical Primary Culture
Fetuses (E15–17) from pregnant mothers were removed using aseptic
techniques. Fetal brains were isolated and placed in Hanks’ balanced
salt solution supplemented with HEPES (10mM), penicillin, streptomy-
cin, and fungizone. Dissected cortical tissue was incubated with
0.25% trypsin for 15 min at 37C and dissociated by repeated tritura-
tion. Cell viability was confirmed by trypan blue exclusion. Cells were
plated in DMEM and supplemented with fetal bovine serum (10%) at
0.7 3 106 cells/well (qRT-PCR) or 200 3 103 cells/well (FISH) in
6-well dishes coated with poly-l-lysine. After 2–3 hr, the media was
changed to neurobasal media, supplemented with B27 and glutamine
(0.5 mM), providing cultures comprised of 90%–95% neurons. Cells
were maintained for 7–10 days in vitro before use in experiments.
The inhibitors U73211, LY294002, and PP2 were obtained from Tocris
Cookson Inc. PTX was obtained from Sigma-Aldrich.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/53/3/439/DC1/..
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